Alexander Jenke

Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals.

Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals.

Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals.

Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals.

Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals.